11 – 20 of 91
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2021
-
Mark
Microenvironmental Impact on Tumour Cell Phenotype and Genotype in Adult and Paediatric Tumours
2021) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Immune checkpoint inhibitors in Wilms' tumor and Neuroblastoma : What now?
(
- Contribution to journal › Article
-
Mark
Refinement of a differentiation protocol using neuroblastoma SH-SY5Y cells for use in neurotoxicology research
2021) In Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association 149. p.1-13(
- Contribution to journal › Article
-
Mark
Anti-tumor effects of rigosertib in high-risk neuroblastoma
(
- Contribution to journal › Article
- 2020
-
Mark
ARNT-dependent HIF-2 transcriptional activity is not sufficient to regulate downstream target genes in neuroblastoma
(
- Contribution to journal › Article
-
Mark
Preclinical investigation of novel therapies against neuroblastoma
2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Discovery of epi-enprioline as a novel drug for the treatment of vincristine resistant neuroblastoma
(
- Contribution to journal › Article
-
Mark
Gene expression signature of acquired chemoresistance in neuroblastoma cells
(
- Contribution to journal › Article
- 2019
-
Mark
Multidimensional intratumour heterogeneity in neuroblastoma
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Anti-tumor effects of PIM/PI3K/mTOR triple kinase inhibitor IBL-302 in neuroblastoma
(
- Contribution to journal › Article